Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multicenter, Pilot Study to Evaluate Next-Dose Transition From Zolpidem to Lemborexant for the Treatment of Insomnia

NCT04009577 is registered in ClinicalTrials.gov with Eisai Inc. as lead sponsor.

NCT NCT04009577
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04009577 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multicenter, Pilot Study to Evaluate Next-Dose Transition From Zolpidem to Lemborexant for the Treatment of Insomnia
Lead sponsor
Eisai Inc.
Phase
Phase 3
Overall status
Completed
Start date
July 15, 2019
Completion date
June 26, 2020
Enrollment
53 (actual)
Sites
17

Conditions

As the registry lists them; a condition with its own page is linked.

insomnia